Regenerative medicine global trends, estimates and forecasts, 2013-2019

YRH: Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-
2019 Overview, Size, Share, Analysis, Technology Developments, Development
Status, Trends, Structure, Production Value and Forecast Research Report
Summary
Global Market Watch:
Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017.
Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017,
growing at a CAGR of 12.2% for the analysis period 2013-2019 respectively.
Skin/Integumentary and Urology together account for approximately 25.97% (2016) of the
market are expected to support the Regenerative Medicine Industry going forward.
Geographical analysis for Regenerative Medicine in Cardiology shows that the highest
Compounded Annual Growth Rate (CAGR) of 18.1% is anticipated from Asia-Pacific region
during the analysis period 2013-2019.
Report Focus:
The report ‘Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019’
reviews the latest trends in regenerative medicine with a perceptive attempt to disclose the
near-future growth prospects. An in-depth analysis on a geographic basis provides strategic
business intelligence for healthcare sector investments. The study reveals profitable
investment strategies for market start-ups, pharmaceutical/biotechnology companies,
laboratories, Contract/Clinical/Commercial Research Organizations (CROs),
government/academic organizations, consulting firms, database buyers and many more in
preferred locations. The report primarily focuses on:
• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies

Estimates are based on online surveys using customized questionnaires by our research team.
Besides information from government databases, company websites, press releases &
published research reports are also used for estimates.
The analysis primarily deals by therapeutic area and biological substitutes. Further, the
subdivided categories include:
Regenerative Medicine – Segmentation
• Therapeutic Area
o Orthopedics
o Skin/Integumentary
o Cardiology
o Neurology
o Urology
o Other
• Biological Substitutes
o Cells and Biomaterials
o Biomolecules
o Manufacturing Factors and
o Other
The period considered for the regenerative medicine market analysis is 2013-2019. The region
wise distribution of the market consists of The Americas (USA, Brazil, Canada and Rest of The
Americas), Europe (Germany, United Kingdom, France, Switzerland, Spain, The Netherlands,
Russia and Rest of Europe), Asia-Pacific (Japan, South Korea, Australia, China, India and Rest
of Asia-Pacific) and Rest of World (Africa and Middle East). The market growth rate in the
major economies such as the U.S., Japan, China etc. are estimated individually.
More than 600 market players are identified in regenerative medicine industry out of which
21 key companies that project improved market activities in the near future are profiled. The
report consists of 99 data charts describing the market shares, sales forecasts and growth
prospects. Moreover, key strategic activities in the market including mergers/acquisitions,
collaborations/partnerships, product launches/developments are discussed.
Get Full Report With Table Of Contents at
http://www.yourresearchhub.com/products/regenerative-medicine-global-
trends-estimates-and-forecasts-2013-2019

Table of contents
I. REPORT FOCUS
I. INTRODUCTION
A. REGENERATIVE MEDICINE – IN BRIEF
HISTORY OF ORGAN ENGINEERING
THE METHODOLOGY OF REGENERATIVE MEDICINE
1) HUMAN SUBSTANCES
2) CELLS AND TISSUES
3) EMBRYONIC STEM CELLS
NUCLEAR TRANSPLANTATION
OPPOSITION TO USE OF EMBRYONIC STEM CELLS AND NUCLEAR TRANSPLANTATION
4) NOVEL MATERIALS
THE COMPETENT ASSOCIATION BETWEEN REGENERATIVE MEDICATION AND PHYSICAL
THERAPEUTICS
CLINICAL TOOLS AND SYNTHETIC ORGANS
MATERIAL TREATMENTS AND BIO SUBSTANCES
CELLULAR TREATMENTS
PREVALENT HURDLES IN THE PROGRESS OF CELLULAR THERAPIES
BARRIERS
SKELETAL MUSCLE
CARDIAC
BONE
OBJECTIVE MEASURES TOWARD REGENERATIVE REHABILITATION
CONCLUSIONS
B. TISSUE ENGINEERING
REGENERATIVE MEDICINE AND TISSUE ENGINEERING
HISTORY OF TISSUE ENGINEERING

METHODS OF TISSUE ENGINEERING
TISSUE ENGINEERING AND REGENERATIVE MEDICINE IN THE CURRENT MEDICAL ORDER
NIH SPONSORED RESEARCH IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE
INFLUENCING STEM CELLS BY MANIPULATING THEIR ENVIRONMENT
TRANSPLANTING HUMAN LIVERS IN MICE
ENGINEERING MATURE BONE STEM CELLS
USING LATTICES TO HELP ENGINEERED TISSUE SURVIVE
POSSIBLE TREATMENT OPTION FOR WORN OUT/INJURED KNEES
RE-GROWING A NEW KIDNEY
TISSUE ENGINEERING AND BIOMATERIALS
CELL AND TISSUE BANKING STANDARDS AND ACCREDITATION
C. STEM CELLS
INTRODUCTION TO STEM CELLS
HISTORY OF STEM CELLS
TYPES OF STEM CELLS
1) EMBRYONIC STEM (ES) CELLS AND EPIBLAST STEM CELLS
2) NON-EMBRYONIC STEM CELLS (NON-ESC)
TISSUE STEM CELLS
INDUCED PLURIPOTENT STEM (IPS) CELLS
REGENERATIVE MEDICINE AND STEM CELLS
THE MICROENVIRONMENT OF THE STEM CELL
EMBRYONIC STEM CELLS A MORE DETAILED LOOK
BLASTOCYST AS A SOURCE OF STEM CELLS LEGAL ISSUES
NON-EMBRYONIC STEM CELLS
1) AMNIOTIC FLUID DERIVED STEM CELLS
2) CORD BLOOD STEM CELLS
TYPE-1 DIABETES
CARDIOVASCULAR CONDITIONS

CENTRAL NERVOUS SYSTEM
3) BONE-MARROW DERIVED STROMAL STEM CELLS
4) IN-VITRO MSC DIFFERENTIATION
5) STEM CELLS DERIVED FROM FAT TISSUE
6) MONOCYTES
STEM CELL TREATMENTS WHY HAVEN’T THEY GAINED WIDESPREAD POPULARITY?
APPLICATIONS OF STEM CELLS IN TREATMENT OF VARIOUS DISEASES AND CONDITIONS
A) BONE
I) BONE DEFECTS
II) FRACTURE NON-UNION
III) OSTEOGENESIS IMPERFECTA
B) CARTILAGE
C) CARDIAC MUSCLE
D) URINARY TISSUES – BLADDER
E) SPINAL CORD
CONCLUSION
CELL-BASED THERAPIES
CELLS DEVELOPED TODAY ARE FUTURE THERAPIES
D. BIOLOGICAL SUBSTITUTES FOR REGENERATIVE MEDICINE
AREAS IN HUMAN TISSUE CONSTRUCTION
BIOMATERIALS
CELLS
BIOMOLECULES
SAFETY AND PRESENTATION CONCERNS
DEVELOPMENTAL FEATURES
OTHER FACTORS
E. REGENERATIVE MEDICINE AND VARIOUS CONDITIONS
1. SKIN/ INTEGUMENTARY

SKIN-TREATMENT
SKIN REVIVAL
NERVE REVIVAL
SKELETAL MUSCLE REVIVAL
REGENERATIVE DRUGS FOR SKIN DISEASES IPS CELLS TO THE SALVAGE
SKIN AND CUTANEOUS CELLS AND TISSUE APPLICATIONS OPT FOR DEVELOPMENT
DO-US ASSOCIATION IN REGENERATIVE MEDICINE TO SUPPORT ACID ATTACK VICTIMS
2. REGENERATIVE MEDICINE’S PROGRESS IN ORTHOPEDICS
CONTEMPORARY NOTIONS
APPROACHES
CELLS
MORPHOGENETIC STIMULUS
SCAFFOLDS
MECHANICAL STIMULATION
ADVANCEMENT
BONE
REGENERATIVE MEDICINE IN THE BONE
CARTILAGE
OTHER ORGANS
A. INTERVERTEBRAL DISK
B. MENISCUS
C. LIGAMENT AND TENDON
GENE THERAPY STRATEGY
GENE THERAPY COMMERCIAL MILESTONES
2013
2012
2010
VIEWPOINTS

3. CARDIAC REGENERATIVE MEDICINE
CARDIOVASCULAR AND REGENERATIVE MEDICINE
OUTLINE
TYPE OF CVD
CARDIOVASCULAR DISEASE AND REVIVAL MEDICINE
AASTROM
AMORCYTE
ATHERSYS INC.’S
CAPRICOR
CYTOMEDIX
CYTORI THERAPEUTICS
JUVENTAS THERAPEUTICS
MESOBLAST’S
4. REGENERATIVE DRUGS FOR NEUROLOGICAL DISABILITIES
REGENERATIVE DRUGS FOR NEUROLOGICAL DISEASES WITH THE USE OF ELECTRICAL
STIMULATION
1. INTRODUCTION
2. ELECTRICAL STIMULUS FOR CEREBRAL INFARCTION
3. LONG-TERM POTENTIATION AND NEUROGENESIS
CONCLUSION
5. REGENERATIVE NEPHROLOGY
REGENERATIVE DRUG STRATEGIES TO HEAL NEUROGENIC BLADDER
INTRODUCTION
6. THE ESSENTIALS OF TISSUE ENGINEERING
BIO-SUBSTANCES USED IN GENITOURINARY TISSUE RENOVATION
CELLS FOR UROGENITAL TISSUE REGENERATION TECHNOLOGIES
TISSUE PROGRAMMING STRATEGIES FOR BLADDER BOOST AND REPLACEMENT
BIOSUBSTANCES SCAFFOLDS FOR BLADDER REGENERATION

REGENERATIVE DRUGS FOR BLADDER USING CELL TRANSPLANTATION
CONCLUSION
7. DIABETES AND REGENERATIVE MEDICINE
8. ALZHEIMER'S AND REGENERATIVE MEDICINE
9. AUTOIMMUNE DISORDERS AND REGENERATIVE MEDICINE
10. REGENERATIVE MEDICINE IN OPHTHALMOLOGY - PROSPECT
PREAMBLE
CELLULAR TREATMENTS
RESULTS - ADVANTAGES
LIMITATIONS
BIO-SUBSTANCES IN THE CORNEA
CORNEAL REPLACEMENTS ARE A POSSIBLE OPTION THAT NEEDS TO ADDRESS
BIO-SUBSTANCES NEED TO BE
OVERVIEW OF KPRO
EXERCISE ENGINEERING STRUCTURE TO CORNEAL DISEASE
F. REGENERATIVE MEDICINE THE FUTURE TRENDS
ALTERED DEMOGRAPHICS CREATE GREATER BURDEN OF CHRONIC DISEASE
AN EMERGING INDUSTRY
OBTAINING REGULATORY NORMS IN PLACE
FDA PROCEDURES
CROSS-AGENCY MANAGEMENT
REGULATORY DISCIPLINE
G. GOVERNMENT FUNDING
PUBLIC AND PRIVATE INVESTMENT EXCEEDS $1 BILLION
H. US HEALTHCARE STATISTICS
THE COST IMPACT OF AN AGING POPULATION
POTENTIAL ECONOMIC IMPACT OF REGENERATIVE MEDICINE

LIST OF TABLES/CHARTS
I. REPORT FOCUS
1. REGENERATIVE MEDICINE THERAPEUTICS COMPANIES BREAKDOWN - %
2. REGENERATIVE MEDICINE CELL & TISSUE BANKS BREAKDOWN - %
3. TISSUE ENGINEERING PRODUCTS CURRENTLY AVAILABLE IN THE MARKET FOR FOLLOWING
AREAS
4. ECONOMIC IMPACT OF VARIOUS DISEASES (IN $USD BILLION)
5. MARKETED CELL THERAPIES BY JURISDICTION FOR USA, EUROPE, SOUTH KOREA, JAPAN,
ISRAEL, CANADA & NEW ZEALAND
6. LEADING COMMERCIAL CELL THERAPY PRODUCTS OF KEY COMPANIES
7. CELL THERAPY TRIALS BY THERAPEUTIC AREA FOR EARLY TO MID-STAGE (PHASE 1, 1/2, 2) -
% BREAKDOWN
8. LIST OF THERAPEUTIC AREAS IDENTIFIED, VECTORS USED AND GENE TYPES TRANSFERRED
IN GENE THERAPY CLINICAL TRIALS
9. USA ANNUAL HEALTHCARE COST PER CAPITA BY AGE (IN $USD)
10. HEALTHCARE EXPENSES IN 2009 BY EXPENSE CATEGORY (FROM HEALTH U.S.A, 2011)
II. REGENERATIVE MEDICINE - MARKET BRIEFING
THE AMERICAS
11. REGENERATIVE MEDICINE - THERAPEUTIC AREA MARKET - ORTHOPEDICS,
SKIN/INTEGUMENTARY, CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER FOR THE
AMERICAS CURRENT TRENDS, ESTIMATES & FORECASTS - (2013-2019, IN USD$ MILLION)
12. REGENERATIVE MEDICINE - THERAPEUTIC AREA - ORTHOPEDICS, SKIN/INTEGUMENTARY,
CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER - % OF THE AMERICAS MARKET VALUE -
(2016-2019)
EUROPE
SKIN/INTEGUMENTARY, CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER FOR EUROPE
CURRENT TRENDS, ESTIMATES & FORECASTS - (2013-2019, IN USD$ MILLION)

CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER - % OF EUROPEAN MARKET VALUE -
(2016-2019)
ASIA-PACIFIC
SKIN/INTEGUMENTARY, CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER FOR ASIA-PACIFIC
CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER - % OF ASIA-PACIFIC MARKET VALUE -
(2016-2019)
REST OF WORLD
SKIN/INTEGUMENTARY, CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER FOR REST OF
WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2013-2019, IN USD$ MILLION)
CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER - % OF REST OF WORLD MARKET VALUE -
(2016-2019)
II. MARKET ANALYSIS
19. GLOBAL REGENERATIVE MEDICINE - SEGMENTATION BY THERAPEUTIC AREAS
REGENERATIVE MEDICINE – GLOBAL
20. REGENERATIVE MEDICINE MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS
- (2013-2019, IN USD$ MILLION)
21. REGENERATIVE MEDICINE - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES &
FORECASTS FOR THE AMERICAS, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2013-2019, IN
USD$ MILLION)
22. REGENERATIVE MEDICINE - % OF THE AMERICAS, EUROPE, ASIA-PACIFIC AND REST OF
WORLD MARKET VALUE - (2016-2019)
REGENERATIVE MEDICINE - BY GEOGRAPHY

THE AMERICAS
23. REGENERATIVE MEDICINE - USA, CANADA, BRAZIL AND REST OF THE AMERICAS - (2013-
2019, IN USD$ MILLION)
24. REGENERATIVE MEDICINE - % OF USA, CANADA, BRAZIL AND REST OF THE AMERICAS
MARKET VALUE - (2016-2019)
EUROPE
25. REGENERATIVE MEDICINE - GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND,
SPAIN, THE NETHERLANDS, RUSSIA AND REST OF EUROPE - (2013-2019, IN USD$ MILLION)
26. REGENERATIVE MEDICINE - % OF GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND,
SPAIN, THE NETHERLANDS, RUSSIA AND REST OF EUROPE MARKET VALUE - (2016-2019)
ASIA-PACIFIC
27. REGENERATIVE MEDICINE - JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST
OF ASIA-PACIFIC - (2013-2019, IN USD$ MILLION)
28. REGENERATIVE MEDICINE - % OF JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND
REST OF ASIA-PACIFIC MARKET VALUE - (2016-2019)
REST OF WORLD
29. REGENERATIVE MEDICINE - AFRICA AND MIDDLE EAST - (2013-2019, IN USD$ MILLION)
30. REGENERATIVE MEDICINE - % OF AFRICA AND MIDDLE EAST MARKET VALUE - (2016-2019)
REGENERATIVE MEDICINE - BY THERAPEUTIC AREA
SKIN/INTEGUMENTARY, CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER FOR GLOBAL
CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER - % OF GLOBAL MARKET VALUE - (2016-
2019)
REGENERATIVE MEDICINE - THERAPEUTIC AREA - BY GEOGRAPHY
ORTHOPEDICS

33. ORTHOPEDICS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES &
USD$ MILLION)
34. ORTHOPEDICS - % OF THE AMERICAS, EUROPE, ASIA-PACIFIC AND REST OF WORLD
THE AMERICAS
35. ORTHOPEDICS MARKET - USA, CANADA, BRAZIL AND REST OF THE AMERICAS - (2013-
2019, IN USD$ MILLION)
36. ORTHOPEDICS - % OF USA, CANADA, BRAZIL AND REST OF THE AMERICAS MARKET VALUE
- (2016-2019)
EUROPE
37. ORTHOPEDICS MARKET - GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND, SPAIN,
THE NETHERLANDS, RUSSIA AND REST OF EUROPE - (2013-2019, IN USD$ MILLION)
38. ORTHOPEDICS - % OF GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND, SPAIN, THE
NETHERLANDS, RUSSIA AND REST OF EUROPE MARKET VALUE - (2016-2019)
ASIA-PACIFIC
39. ORTHOPEDICS MARKET - JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST OF
ASIA-PACIFIC - (2013-2019, IN USD$ MILLION)
40. ORTHOPEDICS - % OF JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST OF
ASIA-PACIFIC MARKET VALUE - (2016-2019)
REST OF WORLD
41. ORTHOPEDICS MARKET - AFRICA AND MIDDLE EAST - (2013-2019, IN USD$ MILLION)
42. ORTHOPEDICS - % OF AFRICA AND MIDDLE EAST MARKET VALUE - (2016-2019)
SKIN/INTEGUMENTARY
43. SKIN/INTEGUMENTARY MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES &
USD$ MILLION)
44. SKIN/INTEGUMENTARY - % OF THE AMERICAS, EUROPE, ASIA-PACIFIC AND REST OF
WORLD MARKET VALUE - (2016-2019)

THE AMERICAS
45. SKIN/INTEGUMENTARY MARKET - USA, CANADA, BRAZIL AND REST OF THE AMERICAS -
(2013-2019, IN USD$ MILLION)
46. SKIN/INTEGUMENTARY - % OF USA, CANADA, BRAZIL AND REST OF THE AMERICAS
EUROPE
47. SKIN/INTEGUMENTARY MARKET - GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND,
SPAIN, THE NETHERLANDS, RUSSIA AND REST OF EUROPE - (2013-2019, IN USD$ MILLION)
48. SKIN/INTEGUMENTARY - % OF GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND,
SPAIN, THE NETHERLANDS, RUSSIA AND REST OF EUROPE MARKET VALUE - (2016-2019)
ASIA-PACIFIC
49. SKIN/INTEGUMENTARY MARKET - JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND
REST OF ASIA-PACIFIC - (2013-2019, IN USD$ MILLION)
50. SKIN/INTEGUMENTARY - % OF JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND
REST OF ASIA-PACIFIC MARKET VALUE - (2016-2019)
REST OF WORLD
51. SKIN/INTEGUMENTARY MARKET - AFRICA AND MIDDLE EAST - (2013-2019, IN USD$
MILLION)
52. SKIN/INTEGUMENTARY - % OF AFRICA AND MIDDLE EAST MARKET VALUE - (2016-2019)
CARDIOLOGY
53. CARDIOLOGY MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES &
USD$ MILLION)
54. CARDIOLOGY - % OF THE AMERICAS, EUROPE, ASIA-PACIFIC AND REST OF WORLD
THE AMERICAS
55. CARDIOLOGY MARKET - USA, CANADA, BRAZIL AND REST OF THE AMERICAS - (2013-2019,
IN USD$ MILLION)

56. CARDIOLOGY - % OF USA, CANADA, BRAZIL AND REST OF THE AMERICAS MARKET VALUE -
(2016-2019)
EUROPE
57. CARDIOLOGY MARKET - GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND, SPAIN,
58. CARDIOLOGY - % OF GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND, SPAIN, THE
ASIA-PACIFIC
59. CARDIOLOGY MARKET - JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST OF
60. CARDIOLOGY - % OF JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST OF ASIA-
PACIFIC MARKET VALUE - (2016-2019)
REST OF WORLD
61. CARDIOLOGY MARKET - AFRICA AND MIDDLE EAST - (2013-2019, IN USD$ MILLION)
62. CARDIOLOGY - % OF AFRICA AND MIDDLE EAST MARKET VALUE - (2016-2019)
NEUROLOGY
63. NEUROLOGY MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES &
USD$ MILLION)
64. NEUROLOGY - % OF THE AMERICAS, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET
VALUE - (2016-2019)
THE AMERICAS
65. NEUROLOGY MARKET - USA, CANADA, BRAZIL AND REST OF THE AMERICAS - (2013-2019,
IN USD$ MILLION)
66. NEUROLOGY - % OF USA, CANADA, BRAZIL AND REST OF THE AMERICAS MARKET VALUE -
(2016-2019)
EUROPE
67. NEUROLOGY MARKET - GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND, SPAIN,

68. NEUROLOGY - % OF GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND, SPAIN, THE
ASIA-PACIFIC
69. NEUROLOGY MARKET - JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST OF
70. NEUROLOGY - % OF JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST OF ASIA-
REST OF WORLD
71. NEUROLOGY MARKET - AFRICA AND MIDDLE EAST - (2013-2019, IN USD$ MILLION)
72. NEUROLOGY - % OF AFRICA AND MIDDLE EAST MARKET VALUE - (2016-2019)
UROLOGY
73. UROLOGY MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS
FOR THE AMERICAS, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2013-2019, IN USD$
MILLION)
74. UROLOGY - % OF THE AMERICAS, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET
VALUE - (2016-2019)
THE AMERICAS
75. UROLOGY MARKET - USA, CANADA, BRAZIL AND REST OF THE AMERICAS - (2013-2019, IN
USD$ MILLION)
76. UROLOGY - % OF USA, CANADA, BRAZIL AND REST OF THE AMERICAS MARKET VALUE -
(2016-2019)
EUROPE
77. UROLOGY MARKET - GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND, SPAIN, THE
NETHERLANDS, RUSSIA AND REST OF EUROPE - (2013-2019, IN USD$ MILLION)
78. UROLOGY - % OF GERMANY, UNITED KINGDOM, FRANCE, SWITZERLAND, SPAIN, THE
ASIA-PACIFIC

79. UROLOGY MARKET - JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST OF ASIA-
PACIFIC - (2013-2019, IN USD$ MILLION)
80. UROLOGY - % OF JAPAN, SOUTH KOREA, AUSTRALIA, CHINA, INDIA AND REST OF ASIA-
REST OF WORLD
81. UROLOGY MARKET - AFRICA AND MIDDLE EAST - (2013-2019, IN USD$ MILLION)
82. UROLOGY - % OF AFRICA AND MIDDLE EAST MARKET VALUE - (2016-2019)
OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE)
83. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) MARKET - GEOGRAPHIC REGION
CURRENT TRENDS, ESTIMATES & FORECASTS FOR THE AMERICAS, EUROPE, ASIA-PACIFIC AND
REST OF WORLD - (2013-2019, IN USD$ MILLION)
84. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) - % OF THE AMERICAS, EUROPE,
ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2016-2019)
THE AMERICAS
85. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) MARKET - USA, CANADA, BRAZIL
AND REST OF THE AMERICAS - (2013-2019, IN USD$ MILLION)
86. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) - % OF USA, CANADA, BRAZIL
AND REST OF THE AMERICAS MARKET VALUE - (2016-2019)
EUROPE
87. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) MARKET - GERMANY, UNITED
KINGDOM, FRANCE, SWITZERLAND, SPAIN, THE NETHERLANDS, RUSSIA AND REST OF EUROPE
- (2013-2019, IN USD$ MILLION)
88. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) - % OF GERMANY, UNITED
KINGDOM, FRANCE, SWITZERLAND, SPAIN, THE NETHERLANDS, RUSSIA AND REST OF EUROPE
ASIA-PACIFIC
89. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) MARKET - JAPAN, SOUTH KOREA,
AUSTRALIA, CHINA, INDIA AND REST OF ASIA-PACIFIC - (2013-2019, IN USD$ MILLION)
90. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) - % OF JAPAN, SOUTH KOREA,
AUSTRALIA, CHINA, INDIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2016-2019)

REST OF WORLD
91. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) MARKET - AFRICA AND MIDDLE
EAST - (2013-2019, IN USD$ MILLION)
92. OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE) - % OF AFRICA AND MIDDLE EAST
REGENERATIVE MEDICINE - BIOLOGICAL SUBSTITUTES - BY TYPE
93. REGENERATIVE MEDICINE - BIOLOGICAL SUBSTITUTES MARKET - CELLS AND -
BIOMATERIALS, BIOMOLECULES, MANUFACTURING FACTORS AND OTHER FOR GLOBAL
94. REGENERATIVE MEDICINE - BIOLOGICAL SUBSTITUTES - CELLS AND BIOMATERIALS,
BIOMOLECULES, MANUFACTURING FACTORS AND OTHER - % OF GLOBAL MARKET VALUE -
(2016-2019)
B. GROWTH RATE ANALYSIS
95. REGENERATIVE MEDICINE MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS
- (2013-2019)
96. REGENERATIVE MEDICINE - BY THERAPEUTIC AREA - % GROWTH RATE FORECASTS FOR
ORTHOPEDICS, SKIN/INTEGUMENTARY, CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER -
(2013-2019)
C. INVESTMENT FOCUS
97. REGENERATIVE MEDICINE - FORECASTED CAGR% - 2013-2019 - TOP 8 COUNTRIES - USA,
BRAZIL, SPAIN, RUSSIA, CHINA, JAPAN, SOUTH KOREA AND INDIA
CARDIOLOGY, NEUROLOGY, UROLOGY AND OTHER - FORECASTED CAGR% - VALUE - 2012-
2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND
BRAZIL
III. INDUSTRY OVERVIEW
99. WORLDWIDE KEY PLAYERS INTO REGENERATIVE MEDICINE INDUSTRY THAT PROJECT
IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE

About Us:
yourresearchhub Not sure if a research on a topic has ever been conducted? Will an existing research
report go in enough detail? Is the report right for me? Have doubts ?
We’re here to help you.
We at Research Hub, are in the field of connected marketing built by a team of highly qualified
professionals with collective knowledge and expertise in both technology as well as global
marketing.
We bring industry research reports from carefully chosen analysts and publishers across the
globe under a single offering to help our clients with quality research and analysis leading to
actionable insight.
A significant portion of our business is organically sourced and this is where we stand out of the
crowd. Our customers come across us mostly while looking for market insights at avenues
where they are looking for genuine advice. We connect with our clients and actively participate
in shaping their research needs – which as a result guaranties a product that they are sure will
benefit them.
Our partners connect with us for the same reasons that our clients conduct their business with
us – the unique model of offering our marketing services. We work very closely with our
partners and bring their strengths to the market in a very effective manner.
Our teams are collocated in India and the UK to provide an unmatched quality of service. Feel
free to contact us at queries@YourResearchHub.Com should you have any questions or
suggestions.
For More Information –
Please call us or write to us:
India: +91 9833351896
UK: +44 208123 7101
Email: sales@yourresearchhub.com
Follow Us –
Browse Blog at http://www.yourresearchhub.com/blogs/news

Regenerative medicine global trends, estimates and forecasts, 2013-2019

Recommended

Recommended

More Related Content

More from Research Hub

More from Research Hub (20)

Recently uploaded

Recently uploaded (20)

Regenerative medicine global trends, estimates and forecasts, 2013-2019